Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology company InterMune plans to offer, subject to market and other conditions, three million shares of its common stock in an underwritten public offering.
Subscribe to our email newsletter
The company expects to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock in connection with the offering.
Goldman, Sachs & Company is acting as the sole book-running manager of the offering. Deutsche Bank Securities will act as co-lead manager and CIBC World Markets will act as co-manager of the offering.